© 1991 British Society for Rheumatology
other |
SEROLOGICAL EVIDENCE OF INFECTION WITH HELICOBACTER PYLORI MAY PREDICT GASTROINTESTINAL INTOLERANCE TO NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) TREATMENT IN RHEUMATOID ARTHRITIS



*Department of Rheumatology, Manchester Royal infirmary Oxford Road, Manchester M13 9WL
Departments of Rheumatology, University Hospital of South Manchester Nell Lane, Manchester M20 8LR
Departments of Microbiology, University Hospital of South Manchester Nell Lane, Manchester M20 8LR
Correspondence to:
Correspondence to Dr S. Jones
Specific circulating antibodies to the spiral gastric organism, Helicobacter pylori (HP) were detectable in 43% of 68 patients with rheumatoid arthritis by complement fixation test (CFT) and enzyme-linked immunosorbent assay (ELISA), a frequency comparable with that of a normal, age-matched population. Presence of these antibodies correlated strongly with a previous history of peptic ulcer disease (PUD) and to the severity of NSAID-related dyspeptic symptoms, the latter often leading to multiple drug intolerance. This contrasts with short term, prospective NSAID toxicity data, which show little relationship between ulceration and HP carriage. This result suggests, however, that HP may have a definite role in the pathogenesis of symptomatic PUD associated with more chronic NSAID usage, and may have important implications for ulcer prophylaxis in these patients.
KEY WORDS: Rheumatoid arthritis, Non-steroidal anti-inflammatory drugs, Peptic ulcer disease, Helicobacter pylori, Antibodies, Dyspepsia
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G Hassett, D J Hart, D V Doyle, L March, and T D Spector The relation between progressive osteoarthritis of the knee and long term progression of osteoarthritis of the hand, hip, and lumbar spine Ann Rheum Dis, May 1, 2006; 65(5): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
